))
Episode 039 - Building a Stakeholder Co-Owned and Governed Pipeline of Novel Therapeutics: Tyler Golato on Molecule Protocol and Decentralized Science
Manage episode 350959549 series 3430533
Contenuto fornito da The Ownership Economy. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The Ownership Economy o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In this episode of the Ownership Economy, we speak with Molecule Protocol’s Co-Founder and Chief Scientific Officer Tyler Golato. Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. The company is connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset. We talk with Tyler about the model, how the company isapproaching progressive decentralization, and where algorithmic rules of governance intersect with the need for human decision making. We hope you enjoy the episode.
Show notes:
- An Open Bazaar for Drug Development: Molecule Protocol | by Paul Kohlhaas
- https://gov.vitadao.com/t/what-are-working-group-stewards/482
- Robert Fine Columbia, cheapest possible cancer interventions
- PsyDAO
- Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
- arXiv.org
- Endurance : : Shackleton's incredible voyage /
- VDP-54.1 Expression of Interest: Pfizer Ventures - Strategic Contributor Proposals - VitaDAO
- Decentralized investor communities gain traction in biotech | Nature Biotechnology
78 episodi
Condividi
